A Pilot Study of Sequential ("First Strike, Second Strike") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for Hormone Positive Metastatic Breast Cancer
Latest Information Update: 06 Feb 2025
At a glance
- Drugs Abemaciclib (Primary) ; Capecitabine (Primary) ; Cyclophosphamide (Primary) ; Docetaxel (Primary) ; Fulvestrant (Primary) ; Granulocyte macrophage colony stimulating factor (Primary) ; Ribociclib (Primary) ; Sacituzumab govitecan (Primary) ; Trastuzumab-deruxtecan (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 16 May 2024 New trial record